Friday, Nov. 13, 2015, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $24.16 to $3,621,256.80.

Highlighted Stocks Traded by Insiders:

Knowles Corporation (KN) - FREE Research Report

Macleod Donald, who is Director at Knowles Corporation, bought 15,000 shares at $15.92 on Nov. 13, 2015. Following this transaction, the Director owned 33,309 shares meaning that the stake was boosted by 81.93% with the 15,000-share transaction.

Eul Hermann, who is Director at Knowles Corporation, bought 1,250 shares at $15.39 on Nov. 13, 2015. Following this transaction, the Director owned 10,609 shares meaning that the stake was boosted by 13.36% with the 1,250-share transaction.

The shares most recently traded at $15.87, up $0.48, or 3.05% since the insider transaction. Historical insider transactions for Knowles Corporation go as follows:

  • 4-Week # shares bought: 5,800
  • 12-Week # shares bought: 7,000
  • 24-Week # shares bought: 13,630

The average volume for Knowles Corporation has been 1.6 million shares per day over the past 30 days. Knowles Corporation has a market cap of $1.4 billion and is part of the technology sector and telecommunications industry. Shares are down 34.61% year-to-date as of the close of trading on Friday.

Knowles Corporation designs, manufactures, and sells products and components to the mobile communications, consumer electronics, medical technology, telecommunications infrastructure, military, aerospace, and industrial markets worldwide. Currently, there is 1 analyst who rates Knowles Corporation a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KN - FREE

TheStreet Quant Ratings

rates Knowles Corporation as a

sell

. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow, generally disappointing historical performance in the stock itself and unimpressive growth in net income. Get the full

Knowles Corporation Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Maximus (MMS) - FREE Research Report

Nadeau Richard John, who is Chief Financial Officer at Maximus, bought 1,000 shares at $53.16 on Nov. 13, 2015. Following this transaction, the Chief Financial Officer owned 6,889 shares meaning that the stake was boosted by 16.98% with the 1,000-share transaction.

The shares most recently traded at $52.21, down $0.95, or 1.82% since the insider transaction. Historical insider transactions for Maximus go as follows:

  • 4-Week # shares bought: 245
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 245
  • 12-Week # shares sold: 21,000
  • 24-Week # shares bought: 245
  • 24-Week # shares sold: 22,000

The average volume for Maximus has been 442,600 shares per day over the past 30 days. Maximus has a market cap of $3.5 billion and is part of the services sector and diversified services industry. Shares are down 5.8% year-to-date as of the close of trading on Friday.

TheStreet Recommends

MAXIMUS, Inc. provides business process services to government health and human services agencies in the United States, Australia, Canada, the United Kingdom, and Saudi Arabia. The company operates through two segments, Health Services and Human Services. The stock currently has a dividend yield of 0.34%. The company has a P/E ratio of 22.6. Currently, there are 4 analysts who rate Maximus a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMS - FREE

TheStreet Quant Ratings

rates Maximus as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Maximus Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Imation (IMN) - FREE Research Report

Robinson Scott, who is VP, Chief Financial Officer at Imation, sold 47,384 shares at $1.99 on Nov. 13, 2015. Following this transaction, the VP, Chief Financial Officer owned 19,396 shares meaning that the stake was reduced by 70.96% with the 47,384-share transaction.

Bosler Greg J, who is Senior VP, Group Pres., CSA at Imation, sold 60,000 shares at $1.77 on Nov. 13, 2015. Following this transaction, the Senior VP, Group Pres., CSA owned 35,584 shares meaning that the stake was reduced by 62.77% with the 60,000-share transaction.

Breedlove John P, who is VP, General Counsel & Corp Sec at Imation, sold 10,000 shares at $1.85 on Nov. 13, 2015. Following this transaction, the VP, General Counsel & Corp Sec owned 25,828 shares meaning that the stake was reduced by 27.91% with the 10,000-share transaction.

The shares most recently traded at $1.75, down $0.10, or 5.71% since the insider transaction. Historical insider transactions for Imation go as follows:

  • 4-Week # shares sold: 6.7 million
  • 12-Week # shares sold: 6.7 million
  • 24-Week # shares sold: 6.7 million

The average volume for Imation has been 125,000 shares per day over the past 30 days. Imation has a market cap of $66.4 million and is part of the technology sector and computer hardware industry. Shares are down 52.77% year-to-date as of the close of trading on Friday.

Imation Corp., together with its subsidiaries, operates as a data storage and data security company worldwide. The company operates in two segments, Tiered Storage and Security Solutions (TSS), and Consumer Storage and Accessories (CSA). Currently, there are no analysts who rate Imation a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on IMN - FREE

TheStreet Quant Ratings

rates Imation as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Imation Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.